Novo Nordisk A/S Class B
Pas de trades
Titres de créance d'entreprises
Vous trouverez ci-dessous la liste des obligations Novo Nordisk A/S Class B, classées par rendement à l'échéance. Les investisseurs optent souvent pour les obligations d'une entreprise en raison de leur stabilité accrue en période de volatilité des marchés. Étudiez les prix, les rendements et autres statistiques et trouvez un investissement fiable.
Symbole | YTM % | Volume | Prix % | Coupon % | Date d'échéance | Montant en suspens | Valeur nominale | Montant min de la dénomination | Émetteur |
|---|---|---|---|---|---|---|---|---|---|
| XXS323295972Novo Nordisk Finance (Netherlands) BV 4.0% 20-NOV-2045 | 4,26% | 0 | 96,53% | 4,000% | 2045-11-20 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS323295590Novo Nordisk Finance (Netherlands) BV 3.625% 20-FEB-2038 | 3,81% | 0 | 98,18% | 3,625% | 2038-02-20 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS300255582Novo Nordisk Finance (Netherlands) BV 3.625% 27-MAY-2037 | 3,73% | 0 | 98,96% | 3,625% | 2037-05-27 | 1,25 B EUR | 1 000,00 EUR | 100 000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS323294453Novo Nordisk Finance (Netherlands) BV 3.375% 20-FEB-2035 | 3,56% | 0 | 98,57% | 3,375% | 2035-02-20 | 600 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS282046075Novo Nordisk Finance (Netherlands) BV 3.375% 21-MAY-2034 | 3,47% | 0 | 99,26% | 3,375% | 2034-05-21 | 1,35 B EUR | 1 000,00 EUR | 100 000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS300255353Novo Nordisk Finance (Netherlands) BV 3.125% 27-MAY-2033 | 3,29% | 0 | 98,93% | 3,125% | 2033-05-27 | 900 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS323293716Novo Nordisk Finance (Netherlands) BV 3.0% 20-FEB-2032 | 3,15% | 0 | 99,17% | 3,000% | 2032-02-20 | 600 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS282045567Novo Nordisk Finance (Netherlands) BV 3.25% 21-JAN-2031 | 3,06% | 0 | 100,89% | 3,250% | 2031-01-21 | 1 B EUR | 1 000,00 EUR | 100 000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS300255329Novo Nordisk Finance (Netherlands) BV 2.875% 27-AUG-2030 | 3,00% | 0 | 99,43% | 2,875% | 2030-08-27 | 1 B EUR | 1 000,00 EUR | 100 000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
 XS244124704Novo Nordisk Finance (Netherlands) BV 1.375% 31-MAR-2030 | 2,89% | 0 | 94,02% | 1,375% | 2030-03-31 | 500 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS300255299Novo Nordisk Finance (Netherlands) BV 2.375% 27-MAY-2028 | 2,74% | 0 | 99,16% | 2,375% | 2028-05-27 | 1,45 B EUR | 1 000,00 EUR | 100 000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS282045460Novo Nordisk Finance (Netherlands) BV 3.125% 21-JAN-2029 | 2,67% | 0 | 101,30% | 3,125% | 2029-01-21 | 1 B EUR | 1 000,00 EUR | 100 000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS323292124Novo Nordisk Finance (Netherlands) BV 2.5% 20-FEB-2029 | 2,66% | 0 | 99,53% | 2,500% | 2029-02-20 | 650 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS282044994Novo Nordisk Finance (Netherlands) BV 3.375% 21-MAY-2026 | 2,61% | 0 | 100,28% | 3,375% | 2026-05-21 | 1,3 B EUR | 1 000,00 EUR | 100 000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XS234803042Novo Nordisk Finance (Netherlands) BV 0.125% 04-JUN-2028 | 2,56% | 0 | 94,33% | 0,125% | 2028-06-04 | 650 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XS244933017Novo Nordisk Finance (Netherlands) BV 1.125% 30-SEP-2027 | 2,39% | 0 | 97,86% | 1,125% | 2027-09-30 | 500 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS300255213Novo Nordisk Finance (Netherlands) BV FRN 27-MAY-2027 | — | 0 | 99,76% | 2,366% | 2027-05-27 | 1,4 B EUR | 1 000,00 EUR | 100 000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS323292027Novo Nordisk Finance (Netherlands) BV FRN 20-NOV-2027 | — | 0 | 100,01% | 2,251% | 2027-11-20 | 650 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novo Nordisk Finance (Netherlands) BV |